Richard Lee, MD, PhD

Articles by Richard Lee, MD, PhD

Management of Lymph Node–Positive Prostate Cancer: The Role of Surgery and Radiation Therapy

ByTimur Mitin, MD, PhD,Michael Blute, MD,Richard Lee, MD, PhD,Jason A. Efstathiou, MD, DPhil

July 15th 2013

Current evidence for the management of lymph node–positive prostate cancer suggests both a disease-control and survival benefit to systemic ADT plus surgery and radiation.

Latest Updated Articles

Management of Lymph Node–Positive Prostate Cancer: The Role of Surgery and Radiation Therapy
July 15th 2013

Trending on CancerNetwork

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)